Skip to Content

PT Kalbe Farma Tbk PTKFF

Morningstar Rating
$0.09 0.00 (2.89%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PTKFF is trading at a 364% premium.
Price
$0.09
Fair Value
$6.42
Uncertainty
High
1-Star Price
$1.13
5-Star Price
$7.98
Economic Moat
Gtnjvr
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PTKFF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.09
Day Range
$0.090.09
52-Week Range
$0.090.14
Bid/Ask
$0.08 / $0.11
Market Cap
$4.28 Bil
Volume/Avg
70,066 / 28,173

Key Statistics

Price/Earnings (Normalized)
22.99
Price/Sales
2.14
Dividend Yield (Trailing)
2.05%
Dividend Yield (Forward)
2.05%
Total Yield
2.05%

Company Profile

PT Kalbe Farma Tbk is a drug manufacturing company that focuses on prescription pharmaceuticals, over-the-counter drugs, energy drinks, and nutrition products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. Majority of the company's gross profits are derived from the distribution and logistics segments. The company operates in Indonesia but has operations across various ASEAN countries, Nigeria, and South Africa.
Sector
Healthcare
Industry
Drug Manufacturers - General
Stock Style Box
Large Core
Total Number of Employees
13,062

Comparables

Valuation

Metric
PTKFF
EPMT
TSPC
Price/Earnings (Normalized)
22.998.858.68
Price/Book Value
3.040.811.09
Price/Sales
2.140.210.66
Price/Cash Flow
17.249.425.84
Price/Earnings
PTKFF
EPMT
TSPC

Financial Strength

Metric
PTKFF
EPMT
TSPC
Quick Ratio
2.451.272.01
Current Ratio
4.312.322.75
Interest Coverage
48.5059.6517.76
Quick Ratio
PTKFF
EPMT
TSPC

Profitability

Metric
PTKFF
EPMT
TSPC
Return on Assets (Normalized)
10.44%6.28%9.85%
Return on Equity (Normalized)
13.70%9.68%14.61%
Return on Invested Capital (Normalized)
12.05%9.52%11.54%
Return on Assets
PTKFF
EPMT
TSPC
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - General Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Eli Lilly and Co
LLY
WcfvrwhyNbl$842.0 Bil
Johnson & Johnson
JNJ
NcxjsrdCcdsg$355.7 Bil
Merck & Co Inc
MRK
KldmpsxPvqkn$328.4 Bil
AbbVie Inc
ABBV
FbpygmtvSmkn$304.0 Bil
AstraZeneca PLC ADR
AZN
DhmjstnhhkPlxbp$243.1 Bil
Roche Holding AG ADR
RHHBY
ZtymnjcpFgwyp$228.5 Bil
Novartis AG ADR
NVS
DdpfwqrBbgm$217.6 Bil
Amgen Inc
AMGN
JqbjxttjQvknh$166.2 Bil
Pfizer Inc
PFE
MfxssvgFtyh$157.2 Bil
Sanofi SA ADR
SNY
LlxxhxwqsLcssn$116.6 Bil

Sponsor Center